A detailed history of Riverview Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Riverview Trust CO holds 3,763 shares of NVS stock, worth $370,241. This represents 0.38% of its overall portfolio holdings.

Number of Shares
3,763
Previous 3,763 -0.0%
Holding current value
$370,241
Previous $400,000 8.0%
% of portfolio
0.38%
Previous 0.38%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 17, 2023

SELL
$92.52 - $104.91 $10,824 - $12,274
-117 Reduced 3.02%
3,763 $379,000
Q1 2023

Apr 20, 2023

BUY
$80.03 - $92.81 $9,363 - $10,858
117 Added 3.11%
3,880 $356,000
Q1 2020

Apr 15, 2020

SELL
$70.67 - $99.01 $133,000 - $186,336
-1,882 Reduced 33.34%
3,763 $310,000
Q4 2019

Jan 10, 2020

SELL
$84.35 - $95.37 $2,699 - $3,051
-32 Reduced 0.56%
5,645 $535,000
Q1 2019

Apr 10, 2019

BUY
$75.32 - $86.15 $2,410 - $2,756
32 Added 0.57%
5,677 $546,000
Q4 2018

Feb 12, 2019

BUY
$73.66 - $82.02 $415,810 - $463,002
5,645 New
5,645 $484,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Riverview Trust CO Portfolio

Follow Riverview Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Riverview Trust CO with notifications on news.